Demyelinating neuropathies triggered by melanoma immunotherapy.
Fuller
G N
GN
Institute of Clinical Neurosciences, University of Sydney, NSW, Australia.
Spies
J M
JM
Pollard
J D
JD
McLeod
J G
JG
D000328:Adult; D006801:Humans; D007167:Immunotherapy / Q000009:adverse effects*; D008297:Male; D008475:Median Nerve / Q000502:physiology / Q000503:physiopathology; D008545:Melanoma / Q000628:therapy*; D008875:Middle Aged; D009431:Neural Conduction; D010292:Paresthesia; D010523:Peripheral Nervous System Diseases / Q000209:etiology* / Q000503:physiopathology; D010543:Peroneal Nerve / Q000502:physiology / Q000503:physiopathology; D012016:Reference Values; D013979:Tibial Nerve / Q000502:physiology / Q000503:physiopathology